Chesneau, B., Aubert‐Mucca, M., Fremont, F., Pechmeja, J., Soler, V., Isidor, B., Nizon, M., Dollfus, H., Kaplan, J., Fares‐Taie, L., Rozet, J., Busa, T., Lacombe, D., Naudion, S., Amiel, J., Rio, M., Attie‐Bitach, T., Lesage, C., Thouvenin, D., Odent, S., Morel, G., Vincent‐Delorme, C., Boute, O., Vanlerberghe, C., Dieux, A., Boussion, S., Faivre, L., Pinson, L., Laffargue, F., Le Guyader, G., Le Meur, G., Prieur, F., Lambert, V., Laudier, B., Cottereau, E., Ayuso, C., Corton‐Pérez, M., Bouneau, L., Le Caignec, C., Gaston, V., Jeanton‐Scaramouche, C., Dupin‐Deguine, D., Calvas, P., Chassaing, N., & Plaisancié, J. (2022). first evidence of SOX2 mutations in Peters' anomaly: Lessons from molecular screening of 95 patients. Clinical genetics, 101(5), 494–506. http://access.bl.uk/ark:/81055/vdc_100154261228.0x000026